These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26439471)

  • 1. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population.
    Hernández-Montoya J; Pérez-Ramos J; Montaño M; Ramírez-Venegas A; Sansores RH; Pérez-Rubio G; Velázquez-Uncal M; Camarena A; Ramos C; Falfán-Valencia R
    Biomark Med; 2015; 9(10):979-88. PubMed ID: 26439471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
    Brzóska K; Bartłomiejczyk T; Sochanowicz B; Cymerman M; Grudny J; Kołakowski J; Kapka-Skrzypczak L; Kruszewski M; Sliwiński P; Roszkowski-Śliż K
    Ann Agric Environ Med; 2014; 21(3):546-51. PubMed ID: 25292126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
    Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
    Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications.
    Mocchegiani E; Giacconi R; Costarelli L
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S11-9. PubMed ID: 22209925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNP-SNP positive interaction between MMP2 and MMP12 increases the risk of COPD.
    Ganbold C; Jamiyansuren J; Munkhzorig E; Dashtseren I; Jav S
    PLoS One; 2024; 19(5):e0301807. PubMed ID: 38771844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP14 gene polymorphisms in chronic obstructive pulmonary disease.
    Saitoh W; Sakamoto T; Hegab AE; Nomura A; Ishii Y; Morishima Y; Kai S; Iizuka T; Kiwamoto T; Matsuno Y; Massoud HH; Massoud HM; Hassanein KM; Sekizawa K
    Int J Mol Med; 2006 Apr; 17(4):621-6. PubMed ID: 16525718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis.
    Zhou H; Wu Y; Jin Y; Zhou J; Zhang C; Che L; Jing J; Chen Z; Li W; Shen H
    Sci Rep; 2013 Oct; 3():2818. PubMed ID: 24085258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population.
    Schirmer H; Basso da Silva L; Teixeira PJ; Moreira JS; Moreira AL; Simon D
    Genet Mol Res; 2009 Aug; 8(3):1028-34. PubMed ID: 19731200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease?
    Wallace AM; Sandford AJ
    Am J Pharmacogenomics; 2002; 2(3):167-75. PubMed ID: 12383023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity.
    Reséndiz-Hernández JM; Sansores RH; Hernández-Zenteno Rde J; Vargas-Alarcón G; Colín-Barenque L; Velázquez-Uncal M; Camarena A; Ramírez-Venegas A; Falfán-Valencia R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1241-51. PubMed ID: 26170653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
    Cheng SL; Yu CJ; Yang PC
    Biochem Genet; 2009 Aug; 47(7-8):591-601. PubMed ID: 19507017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population.
    Pérez-Rubio G; Silva-Zolezzi I; Fernández-López JC; Camarena Á; Velázquez-Uncal M; Morales-Mandujano F; Hernández-Zenteno Rde J; Flores-Trujillo F; Sánchez-Romero C; Velázquez-Montero A; Espinosa de Los Monteros C; Sansores RH; Ramírez-Venegas A; Falfán-Valencia R
    COPD; 2016 Oct; 13(5):610-5. PubMed ID: 27078193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in matrix metalloproteinase-1, -9 and -12 genes and the risk of chronic obstructive pulmonary disease in a Korean population.
    Lee SY; Kim MJ; Kang HG; Yoo SS; Choi YY; Lee WK; Cha SI; Kim CH; Jung TH; Park JY
    Respiration; 2010; 80(2):133-8. PubMed ID: 20160424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ADAM33 gene polymorphisms with COPD in the Mongolian population of China.
    Tan J; Liu AP; Sun C; Bai YF; Lv F
    Ann Hum Biol; 2014; 41(1):9-14. PubMed ID: 24191661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype in
    Ponce-Gallegos MA; Pérez-Rubio G; García-Carmona A; García-Gómez J; Hernández-Zenteno R; Ramírez-Venegas A; Falfán-Valencia R
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
    van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
    Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.
    Bchir S; Nasr HB; Hakim IR; Anes AB; Yacoub S; Garrouch A; Benzarti M; Bauvois B; Tabka Z; Chahed K
    Mol Diagn Ther; 2015 Dec; 19(6):375-87. PubMed ID: 26303146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.